Bleeding from the lower gastrointestinal (GI) tract shouldn't be seen as simply a manageable adverse effect of oral anticoagulation (OAC) for atrial fibrillation (AF). Rather, it's a red flag that the ...

ATLANTA, Georgia — Patients with atrial fibrillation receiving anticoagulant therapy are more likely to experience gastrointestinal (GI) bleeding when treated with rivaroxaban than when treated with ...

Symptoms of GI bleeding include stomach pain, vomiting blood, or having black, tarry stool. Peptic ulcers are the leading cause of upper GI bleeding, while diverticular disease is the most common ...

LONG BEACH, Calif. -- People with advanced chronic kidney disease (CKD) faced higher rates of potentially fatal gastrointestinal bleeding, a retrospective study found. Those with stage 5 CKD had a 40% ...

Among Medicare-certified, single-specialty ASCs, endoscopy is the most common focus, and more than one-third (37%) 1 of certified multi-specialty ASCs have an endoscopy service line. Patient volumes ...

The risk for newly diagnosed gastrointestinal (GI) bleeding is increased for patients undergoing hemodialysis (HD) versus peritoneal dialysis (PD), according to a study published online Jan. 2 in ...

Rivaroxaban (Xarelto; Bayer/Janssen) carries a significantly higher risk of gastrointestinal bleeding—including major GI bleeding—than do other direct oral anticoagulants (DOACs) across a real-world ...

Please provide your email address to receive an email when new articles are posted on . Chan and colleagues assessed data on 19,114 patients from Aspree, an aspirin primary prevention trial. In the ...

In a clinical practice guideline issued jointly by the American College of Gastroenterology and the Canadian Association of Gastroenterology and published online March 17 in the American Journal of ...

Please provide your email address to receive an email when new articles are posted on . Bleeding in the lower gastrointestinal tract increased risk for incident colorectal cancer in patients with ...

Pantoprazole yields lower clinically important upper GI bleeding, with no significant change in mortality vs placebo. HealthDay News — Pantoprazole results in a significantly lower risk for clinically ...

New guidelines regarding medications for gastrointestinal bleeding were jointly released by the American College of Gastroenterology and the Canadian Association of Gastroenterology on March 21. This ...